Clicky

Taysha Gene Therapies, Inc.(TSHA) News

Date Title
Oct 3 Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?
Sep 26 Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress
Jun 25 Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jun 18 Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Jun 18 Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
May 15 Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 14 Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates
May 14 Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 7 Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
May 2 Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
May 2 Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
Apr 29 These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
Apr 20 Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher
Apr 15 Certain Biotech Investors Get an Early Look at Results. Is That Fair?
Apr 5 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 24 News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts
Mar 21 Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations
Mar 20 Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript
Mar 20 Q4 2023 Taysha Gene Therapies Inc Earnings Call
Mar 19 Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates